Euroapi S.A.S.U. | Mid-cap | Healthcare

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Income Metrics

Balance Sheet Metrics

Total Assets 1.4B
Total Liabilities 488.4M
Shareholders Equity 953.5M
Debt to Equity 0.51

Cash Flow Metrics

Revenue & Profitability Trend

Euroapi S.A.S.U Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue i919.2M1.0B980.9M892.8M944.6M
Cost of Goods Sold i776.8M854.3M804.0M783.7M854.1M
Gross Profit i142.4M164.6M176.9M109.1M90.4M
Gross Margin % i15.5%16.2%18.0%12.2%9.6%
Operating Expenses
Research & Development i25.8M29.6M21.8M17.0M19.9M
Selling, General & Administrative i127.0M130.9M128.2M89.4M69.6M
Other Operating Expenses i---5.4M10.6M
Total Operating Expenses i152.8M160.5M150.0M111.8M100.1M
Operating Income i-8.4M4.5M27.1M1.5M-8.4M
Operating Margin % i-0.9%0.4%2.8%0.2%-0.9%
Non-Operating Items
Interest Income i6.0M800.0K8.2M200.0K1.0M
Interest Expense i20.3M10.6M4.2M2.1M1.2M
Other Non-Operating Income-----
Pre-tax Income i-139.6M-242.8M3.1M-14.6M-11.8M
Income Tax i-9.0M-53.0M18.2M-6.5M-5.5M
Effective Tax Rate % i0.0%0.0%587.1%0.0%0.0%
Net Income i-130.6M-189.7M-15.1M-8.1M-6.3M
Net Margin % i-14.2%-18.6%-1.5%-0.9%-0.7%
Key Metrics
EBITDA i69.4M309.4M129.7M77.8M64.0M
EPS (Basic) i€-1.38€-2.02€-0.16€-0.09€-0.07
EPS (Diluted) i€-1.38€-2.02€-0.16€-0.09€-0.07
Basic Shares Outstanding i9450000094200000937000009402688894026888
Diluted Shares Outstanding i9450000094200000937000009402688894026888

Income Statement Trend

Euroapi S.A.S.U Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets
Cash & Equivalents i73.0M34.5M74.5M10.3M100.0K
Short-term Investments i6.2M8.4M4.8M19.0M153.8M
Accounts Receivable i161.3M216.2M264.2M238.9M194.7M
Inventory i524.1M644.8M594.8M569.5M584.1M
Other Current Assets44.6M200.0K-100.0K86.3M8.4M
Total Current Assets i830.1M979.1M1.0B905.0M983.6M
Non-Current Assets
Property, Plant & Equipment i10.6M8.8M6.8M631.7M1.5B
Goodwill i38.1M43.4M28.6M26.8M5.4M
Intangible Assets i38.1M34.2M28.6M26.8M5.4M
Long-term Investments-----
Other Non-Current Assets4.7M8.9M14.9M9.7M-
Total Non-Current Assets i659.2M633.1M712.5M717.0M617.5M
Total Assets i1.5B1.6B1.7B1.6B1.6B
Liabilities
Current Liabilities
Accounts Payable i104.9M159.6M219.6M189.6M131.1M
Short-term Debt i56.0M210.0M104.6M5.4M58.0M
Current Portion of Long-term Debt-----
Other Current Liabilities2.3M9.8M10.1M191.7M54.7M
Total Current Liabilities i328.7M509.1M456.5M386.7M365.3M
Non-Current Liabilities
Long-term Debt i13.2M15.5M16.2M18.7M15.4M
Deferred Tax Liabilities i01.6M6.3M5.6M11.2M
Other Non-Current Liabilities-400.0K-200.0K-100.0K100.0K
Total Non-Current Liabilities i177.2M175.5M169.4M219.4M246.3M
Total Liabilities i505.9M684.6M625.9M606.1M611.6M
Equity
Common Stock i95.6M95.1M94.6M90.0M90.0M
Retained Earnings i-----
Treasury Stock i2.0M1.9M1.3M--
Other Equity-----
Total Shareholders Equity i983.6M927.8M1.1B1.0B989.4M
Key Metrics
Total Debt i69.2M225.5M120.8M24.1M73.4M
Working Capital i501.4M470.0M567.1M518.3M618.3M

Balance Sheet Composition

Euroapi S.A.S.U Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income i-130.6M-189.7M-15.0M-8.1M-6.3M
Depreciation & Amortization i-----
Stock-Based Compensation i---1.8M1.6M
Working Capital Changes i206.6M-15.8M-87.8M-66.5M22.3M
Operating Cash Flow i101.8M-191.8M-89.4M-73.3M17.2M
Investing Activities
Capital Expenditures i-108.0M-132.8M-167.4M-87.9M-88.3M
Acquisitions i0-4.5M0--
Investment Purchases i-----
Investment Sales i-----
Investing Cash Flow i-108.0M-137.3M-167.4M-87.9M-88.3M
Financing Activities
Share Repurchases i-100.0K-600.0K-1.3M0-
Dividends Paid i-----4.7M
Debt Issuance i197.3M0---
Debt Repayment i-----
Financing Cash Flow i42.9M105.6M195.3M29.0M-5.8M
Free Cash Flow i14.9M-127.7M-122.6M-17.1M8.4M
Net Change in Cash i36.7M-223.5M-61.5M-132.2M-76.9M

Cash Flow Trend

Euroapi S.A.S.U Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 8.84
Forward P/E -27.37
Price to Book 0.42
Price to Sales 0.35
PEG Ratio -27.37

Profitability Ratios

Profit Margin -14.08%
Operating Margin 3.21%
Return on Equity -13.49%
Return on Assets -0.67%

Financial Health

Current Ratio 2.53
Debt to Equity 7.17
Beta 0.70

Per Share Data

EPS (TTM) €-1.31
Book Value per Share €7.91
Revenue per Share €9.33

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
eapi312.7M8.840.42-13.49%-14.08%7.17
Ipsen S.A 9.7B21.642.2710.89%11.91%22.74
Vetoquinol S.A 926.3M15.411.6310.80%11.26%3.13
Boiron S.A 468.6M23.961.255.22%3.84%4.90
AB Science S.A 85.9M-8.80-32.97%116.42%-0.78
CoreTech Limited 2.2M---102.42%137.36%-0.95

Financial data is updated regularly. All figures are in the company's reporting currency.